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Abstract
An adverse maternal environment (AME) and Western diet (WD) in early life
predispose offspring toward cognitive impairment in humans and mice. Cognitive impairment associates with hippocampal dysfunction. An important regulator of hippocampal function is the hippocampal Nociceptin/Orphanin FQ
(N/OFQ) system. Previous studies find links between dysregulation of hippocampal N/OFQ receptor (NOP) expression and impaired cognitive function.
NOP is encoded by the opioid receptor-like 1 (Oprl1) gene that contains multiple mRNA variants and isoforms. Regulation of Oprl1 expression includes histone modifications within the promoter. We tested the hypothesis that an
AME and a postweaning WD increase the expression of hippocampal Oprl1
and select variants concurrent with altered histone code in the promoter. We
created an AME-WD model combining maternal WD and prenatal environmental stress plus postweaning WD in the mouse. We analyzed the hippocampal expression of Oprl1, Oprl1 variants, and histone modifications in the Oprl1
promoter in offspring at postnatal day (P) 21 and P100. An AME and an AMEWD significantly increased the total hippocampal expression of Oprl1 and variant V4 concurrently with an increased accumulation of active histone marks
in the promoter of male offspring. We concluded that an AME and an AMEWD alter hippocampal Oprl1 expression in offspring through an epigenetic
mechanism in a variant-specific and sex-specific manner. Altered hippocampal
Oprl1 expression may contribute to cognitive impairment seen in adult males
in this model. Epigenetic regulation of Oprl1 is a potential mechanism by
which an AME and a WD may contribute to neurocognitive impairment in
male offspring.
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1 | INTRODUCTION
The maternal environment mediates the long-term
health of offspring in both humans and animals (Alastalo
et al., 2013; Arcego et al., 2016; Barker et al., 1993; Ke
et al., 2020; Tozuka et al., 2010). An adverse maternal
environment (AME) appears to increase the likelihood of
multiple later life pathophysiologies. For example, maternal poverty predisposes offspring toward later life obesity
in the United States (Levine, 2011). More than 14% of
total US population and 3.4 million more children are
currently living in poverty (Parolin et al., 2022). Additionally, a Western diet (WD) has been a significant contributor to the growing rate of obesity over the last several
decades (Rakhra et al., 2020).
An AME and the consumption of a WD in early postnatal life increase the risk for cognitive impairment later in life
in humans (Alastalo et al., 2013; Barker et al., 1993;
Cordner et al., 2019) and animal models (Arcego
et al., 2016; Tozuka et al., 2010; Weaver et al., 2004). We
previously demonstrated that AME together with postweaning WD impair learning and memory function in
adult male mice (Ke et al., 2020). Moreover, AME male offspring demonstrate reduced hippocampal neurogenesis
(Ke, Huang, et al., 2021). However, the pathogenesis underlying these changes remain poorly understood. Cognitive
functions involve many signaling pathways including the
Nociceptin/Orphanin FQ (N/OFQ) system in the hippocampus (Andero, 2015; Sardari et al., 2015; Zaveri, 2003).
The N/OFQ system in the hippocampus plays an essential
role in cognitive functions in adult humans and animals
(Andero, 2015; Zaveri, 2003). While several signaling pathways have been found to be programmed by AME (CriadoMarrero et al., 2020; Lemche, 2018; Pillai et al., 2018; Wang
et al., 2020), the effects of AME on N/OFQ system in developing hippocampus remain unknown.
N/OFQ participates in numerous physiological functions though binding to the nociceptin opioid peptide
receptor (NOP) (Lambert, 2008). The opioid receptor-like
1 (Oprl1) gene encodes NOP, which exists as a member
of the opioid subfamily of G protein-coupled receptors
(Mollereau et al., 1994). N/OFQ and NOP are widely
express in the central nervous system and peripheral
organs and participate in many processes including
learning and memory (Andero, 2015; Bodnar, 2013;
Mallimo & Kusnecov, 2013). NOP activates Gi/o proteins,
a family of heterotrimeric G protein alpha subunits that
primarily inhibit the cAMP dependent pathway and thus
inhibits neuronal activity (Mouledous, 2019). NOP agonism impairs learning and memory whereas NOP antagonists have been shown to block this effect (Redrobe
et al., 2000; Sardari et al., 2015). Moreover, studies in
transgenic Pnoc/Oprl1 knockout mice correlate with
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pharmacological studies, indicating that decreased activation of NOP is associated with enhanced memory
(Andero, 2015). In contrast, NOP activation impairs
memory (Andero, 2015). Importantly, N/OFQ-NOP
receptor memory functions appear vulnerable to physiological stress (Mallimo & Kusnecov, 2013).
Most species demonstrate significant conservation of
the Oprl1 gene, which produces multiple mRNA variants
due to alternative splicing (Curro et al., 2001; Pan
et al., 1998). The mouse Oprl1 gene contains 4 exons.
Alternative splicing of mouse Oprl1 gene generates
12 mRNA variants (V) and multiple isoforms. V1–4, 8–9,
and 12 are protein coding transcripts. Transcripts V5–7
undergo nonsense mediated decay and V10–11 are noncoding transcripts (ENSMUSG00000027584). Five of the
Oprl1 splicing variants are differentially expressed in various mouse brain regions (Pan et al., 1998). Given that
different variants and isoforms display different biological functions and pharmacological effects (Pan
et al., 1998), delving into the expression pattern of Oprl1
splicing variants in the hippocampus exposed to AME
and AME-WD will likely be more informative than looking solely at the total expression.
Regulation of Oprl1 expression and alternative splicing involves histone covalent modifications, including
histone acetylation (ac) and methylation (me) (Caputi
et al., 2014, 2016). For example, histone H3 lysine (K) 9
acetylation (ac), H3K14ac, and H3K4 trimethylation
(me3) in the promoter region lead to gene activation
while H3K36me3 marks actively transcribed regions
(Black et al., 2012; Graff & Tsai, 2013). In contrast,
H3K9me3 and H3K27me3 in the promoter region lead to
gene silencing (Black et al., 2012). All of these histone
marks display vulnerability to perinatal insults (Ke
et al., 2010, 2011).
Despite this previous work elucidating the impact
of AME on neurodevelopmental issues such as memory
and learning as well as hippocampal neurogenesis, the
effects of AME and AME-WD on the expression of
Oprl1 and its variant composition in the hippocampus
are unknown. We hypothesized that AME and AMEWD would alter variant expression of Oprl1 and Oprl1
promoter histone code.

2 | METHODS
2.1 | Animals
All experiments were conducted in accordance with the
Public Health Services Policy on Human Care and Use of
Laboratory Animals and all procedures were approved by
the Medical College of Wisconsin Institutional Animal Care
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and Use Committee (American Physiological Society &
World Medical Association General Assembly, 2002). In this
study, we used the mouse model of the AME that has been
previously described (Ke et al., 2020). In brief, the AME was
induced in mice by exposing 6-week-old C57/Bl6 female
mice randomly to either a control diet (CD) or a WD
(Ke et al., 2020). Dams in the CD group experienced a normal environment throughout pregnancy and are designated
as Control (Con). Dams fed a WD experienced a “stressed”
environment the last third of pregnancy. The combination
of chronic WD and gestational stress is designated as AME
(Ke et al., 2020). Dams from both Con and AME groups
delivered spontaneously, and litters were culled to six, with
three female and three male pups in each litter. At postnatal day 21 (P21), pups from both Con and AME groups were
either sacrificed for studying the immediate effect of AME
or weaned and permanently placed on either a CD or a
WD, creating four experimental groups: Con-CD, Con-WD,
AME-CD, AME-WD for a later time point study (Ke
et al., 2020). At P100, when the mice were clearly adults at
this stage and post the changes that occur in adolescent as
well as are not in senescence, pups from four experimental
groups were anesthetized, sacrificed, and the hippocampi
(HP) were dissected for molecular studies. For immunohistochemistry (IHC) studies, animals were individually fixed
via intra-cardiac perfusion with 4% paraformaldehyde in
PBS, brains were removed and prepared for paraffin sectioning as previously described (Ke et al., 2022; Ke, Huang,
et al., 2021). A total of 40 pregnant female mice were used
in the study (Ke et al., 2020). One male and one female pup
from the same litter were used and counted as N = 1. To
have a N of six, six males and six females from six different
litters were used for each experiment with N = 6 L/group.
HP from control mice at P7, P21 and P100 were also harvested for the determination of the Oprl1 alternative splicing variant expression pattern developmentally.

2.2 | RNA isolation and real-time
Reverse Transcription Polymerase Chain
Reaction (RT-PCR)
Total RNA extraction and cDNA syntheses were performed as previously described (Cohen et al., 2016).
mRNA levels of Oprl1 total (Mm.PT.58.5266522.g, Integrated DNA Technologies) and its splicing variants were
calculated relative to hypoxanthine phosphoribosyltransferase 1 (HPRT1, Mm.PT.39a.22214828, Integrated DNA
Technologies), which was used as an internal control.
Primer and probe sequences for Oprl1 variants were
designed based on the sequences obtained from Ensembl.
org (ENSMUSG00000027584) and are listed in Table 1. A
unique primer set was designed for each variant. Either a
forward or reverse primer crossed the exon junction for
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all variants except for V8–9 and V12. The primer sets for
V8–9 and V12 crossed the coding and noncoding junctions. All primer sets were confirmed by sequencing. The
corresponding locations are shown in the schematic representation of Oprl1 splicing variants in Figure 4b.

2.3 | Protein isolation and immunoblot
Hippocampal tissue proteins' isolation and immunoblots
were performed as previously described (Cohen et al.,
2016). Antibody against Oprl1 (ThermoFisher Scientific,
Cat#PA5-70443) at 1:50 dilution was used to determine
protein abundance and Vinculin (Cell Signaling, Cat
#13901) at 1:10000 dilution was used as a loading
control.

2.4 | Immunohistochemistry
IHC was used to localize Oprl1 expression in the hippocampus at P21 and P100. IHC was performed by the Histology Core Lab in the Department of Pathology Medical
College of Wisconsin using a Leica Bond Rx automated
staining platform as previously described (Ke et al.,
2022). A rabbit anti-Oprl1 (Cat# bs-0181R, Bioss
Antibodies Inc.) 1:100 was used to determine Oprl1 protein abundance in three hippocampal subregions (CA1,
CA3, and denate gyrus [DG]). The percentage of Oprl1
positive cell density of each hippocampal subregion area
was quantified by imageJ.

2.5 | Chromatin isolation and chromatin
immunoprecipitation assay
Hippocampal chromatin isolations and chromatin immunoprecipitation assays with antibodies against histone H3
lysine (K) 4 trimethylation (H3K4me3, #9751, Cell Signaling Technology), H3K9me3 (#13969, Cell Signaling
Technology), H3K27me3 (#9733, Cell Signaling Technology), H3K36me3 (#4909, Cell Signaling Technology),
H3K9 acetylation (H3K9ac, #9649, Cell Signaling
Technology), and H3K14ac (#7627, Cell Signaling Technology) were performed as previously described
(Ke et al., 2022; Ke, Huang, et al., 2021). Real-time PCR
was used to quantitate the amount of DNA from the
Oprl1 promoter with primers and probe listed in Table 1.

2.6 | Statistics
GraphPad Prism 6 (GraphPad Software, San Diego, CA)
was used to perform all analyses. All data presented are
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50 CTTGGTGTGCATGACGAG
50 CTCCCAGCTGAGGATGA

50 TTGGACTCAAGGTCACCATC

50 GGGCTCTACTTGGCTGT

V3

V4

50 TCAGTCTCTCTTAAGACTCCTCTC
50 ACCAGGCACTCGATCTCT

50 TGTATGTCATCCTCAGACAACATT

50 AGTGGAGGATGAAGGTCAGT

V7

V8

Abbreviation: ChIP, chromatin immunoprecipitation.

Oprl1 promoter

50 CAGTGCGGCAGCCAGAA

50 CCACAGAGCCCATCTACACCCAAC

50 AGATGCAGATGGCAAATACAGGGC

50 CTCAGTGGACTGTGTCCAGCACTG

50 AGTCCTCCTCCCTGACCAATCAGT

50 TGAACTTTACAGGCAGTGCCCTGA

50 AGCATCTCTCTCTCTTGATTCCTTCCACA

50 CTCTACTTGGCTGTGTGCATCGGG

50 CATACATGACGAGGCAGTTCCC

50 CTCTACTTGGCTGTGTGCATCGGG

50 TTCTGGGAGGTCTTGTATGGCAGC

50 TTCTGGGAGGTCTTGTATGGCAGC

Probe
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50 TTTGGCTTCCTTCTCCAACCTGCG

50 AGTTCAGGGTCAACCTAGAGAG

50 ATGACTAGGCGTGGACCT

V12

50 TGTGTCTTGTGTGAGCCGATTT

50 GCAGACAGAGATGATCAGAACC

50 TTGGAGAGATCGAGTGCCT

V10

ChIP

5 CTGGAACAGGACACAGAAAGA

5 TCATGTGCCTGTTAGTGTAGTT

V9

0

50 TGGTGTGCCTGAATGTGAA

50 CTCTGAGAGGAGTCTTAAGAGAGA

V6

0

5 CAATGCCCTCCCAGATGAC

5 CTTGGACTCAAGGTCACCATC

V5

0

50 GAGACAGGTTCCCTTGAAAGT

50 CCCTAATATGAGGAACTGTACTGAG

V2

0

50 GAGACAGGTTCCCTTGAAAGT

50 CTGTTGGAGGAACTGTACTGAG

Reverse

V1

Oprl1

Forward

Primers for real time RT-PCR and ChIP assays

Real-time RT-PCR

TABLE 1
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F I G U R E 1 Hippocampal Oprl1 total mRNA and protein levels in P21 and P100 offspring. Data were presented as mean ± SD.
(a) Hippocampal Oprl1 total mRNA levels in P21. (b) Hippocampal Oprl1 protein levels in P21. *p < .05, **p < .01 when compared to sexmatched control. (c) Hippocampal Oprl1 total mRNA levels in P100. (d) Hippocampal Oprl1 protein levels in P100. N = 6 L/group. *p < .05
when compared to sex-matched con-CD, #p < .05 when compared to sex-matched con-WD, &p < .05 when compared to sec-matched AMECD. AME, adverse maternal environment; CD, control diet; WD, Western diet

expressed as mean ± SD. Adequate technical and biological replicates were used for all experiments. Four-group
comparisons were analyzed by ANOVA followed by
post-hoc Tukey's multiple comparisons test. Two-group
comparisons were analyzed by Mann–Whitney (nonparametric) test. Significance was set as p < .05.

3 | R E SUL T S
3.1 | AME and AME-WD increased
hippocampal Oprl1 expression in males at
P21 and P100
We first determined the effects of AME on hippocampal
Oprl1 expression at P21, immediately following exposure
to maternal insults. In P21 males (M), AME significantly

increased hippocampal Oprl1 total mRNA and protein
levels compared to controls (Con) (Figure 1a,b). In P21
females (F), AME also significantly increased hippocampal Oprl1 total mRNA levels compared to the controls
(Figure 1a). However, AME did not affect hippocampal
Oprl1 protein levels in females compared to the controls
(Figure 1b).
We next determined the effects of an AME-WD on
hippocampal Oprl1 expression at P100 when the adult
males displayed learning and memory deficits. In P100
males, similarly, the AME-WD significantly increased
hippocampal Oprl1 total mRNA levels when compared to
either Con male CD group (ConM-CD) or ConM WD
group (ConM-WD) (Figure 1c). AME-WD also significantly increased hippocampal protein levels when compared to either ConM-CD or ConM-WD or AMEM-CD
(Figure 1d). In P100 females, however, neither AME
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F I G U R E 2 Oprl1 protein abundance in P21 hippocampal subregions. (a–f) Oprl1 abundance in P21 female hippocampal CA1 (a and d),
CA3 (b and e), and DG (c and f) in Con (a–c) versus AME (d–f). (g–l) Oprl1 abundance in P21 male hippocampal CA1 (g and j), CA3 (h and
k), and DG (i and l) in Con (g–i) versus AME (j–l). Red arrows pointed cells represent Oprl1 positive cells while black arrows pointed cells
represent Oprl1 negative cells. (m) Quantifications of Oprl1 positive cell density. Data were presented as mean ± SD. N = 4 L/group. Scale
bar = 100 μm, *p < .05 when compared to sex-matched control. AME, adverse maternal environment; DG, dentate gyrus

F I G U R E 3 Oprl1 protein abundance in P100 hippocampal subregions. (a–l) Oprl1 abundance in P100 female hippocampal CA1 (a, d, g,
and j), CA3 (b, e, h, and k), and DG (c, f, i, and l) in Con-CD (a–c), Con-WD (d–f), AME-CD (g–i), and AME-WD (j–l). (m–x): Oprl1
abundance in P100 male hippocampal CA1 (m, p, s, and v), CA3 (n, q, t, and w), and DG (o, r, u, and x) in Con-CD (m–o), Con-WD (p–r),
AME-CD (s–u), and AME-WD (v–x). Red arrows pointed cells represent Oprl1 positive cells while black arrows pointed cells represent Oprl1
negative cells. (y) Quantifications of Oprl1 positive cell density. Data were presented as mean ± SD. Scale bar = 100 μm, N = 4 L/group.
*p < .05 when compared to sex-matched Con-CD, #p < .05 when compared to sex-matched Con-WD, &p < .05 when compared to secmatched AME-CD. AME, adverse maternal environment; CD, control diet; DG, dentate gyrus; WD, Western diet

alone, WD alone nor the combination of the two altered
hippocampal Oprl1 expression in either mRNA or protein
levels (Figure 1c,d).

Using IHC, we found that in P21, increased Oprl1
abundance was mainly in CA3 region of hippocampus in
AME males (AMEM) when compared to sex-matched
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F I G U R E 4 Histone code in Oprl1 promoter region in male hippocampi at P21 and P100. Data were presented as mean ± SD.
(a) Histone code in P21 male hippocampi. *p < .05 when compared to ConM. (b) Histone code in P100 male hippocampi. N = 6 L/group.
*p < .05 when compared ConM-CD, #p < .05 when compared to ConM-WD, &p < .05 when compared to AMEM-CD. AME, adverse
maternal environment; CD, control diet; WD, Western diet;

controls with no difference in the Oprl1 expression in any
hippocampal subregions in females between ConF and
AMEF groups (Figure 2a–m). In P100 males, increased
Oprl1 expression was predominant in CA1 and CA3
regions in AMEM-WD when compared to ConM-CD.
Furthermore, increased Oprl1 expression was noted in
CA1 and DG regions in AMEM-WD when compared to
AMEM-CD indicating a diet effect. Meanwhile, increased
Oprl1 expression was also observed in CA3 region in
AMEM-WD when compared to ConM-WD indicating an
AME effect (Figure 3a–y). In P100 females, interestingly,
decreased Oprl1 expression was noted in CA3 region in
ConF-WD compared to ConF-CD. Additionally,
decreased Oprl1 expression was also noted in CA1 region
in AMEF-WD compared to AMEF-CD. The data in P100
females indicate a diet effect. Together, our data suggest
that an AME and an AME-WD affect hippocampal Oprl1
expression in a sex-specific manner.

3.2 | AME and AME-WD increased
hippocampal densities of active histone
marks in the Oprl1 promoter in males at
P21 and P100
Given that AME and AME-WD display consistent effects
upon the expression of Oprl1 in male HP and Oprl1
expression is known to be regulated in part by histone
modifications in the promoter region, we examined the
effect of AME on histone modifications in Oprl1 promoter in male HP at P21 and P100. In P21 males, AMEM
significantly increased hippocampal densities of active
histone marks H3K9ac, H3K14ac, and H3K36me3 in the
Oprl1 promoter region when compared to the controls
(Figure 4a). In P100 males, AMEM-WD significantly
increased hippocampal H3K9ac densities in Oprl1

promoter when compared to either ConM-CD or ConMWD or AMEM-CD. AMEM-WD also significantly
increased H3K36me3 in the promoter region when compared to either ConM-CD or ConM-WD (Figure 4b).
Additionally, both AMEM-CD and AMEM-WD significantly increased H3K14ac densities in Oprl1 promoter
region when compared to ConM-CD, indicating an AME
effect. Surprisingly, AMEM had similar effect on
H3K27me3 densities in both CD and WD groups.

3.3 | Developmental expression of Oprl1
alternative splicing mRNA variants in
control mouse HP
Alternative splicing of Oprl1 generates multiple mRNA
variants (Figure 5a,b). Different variants and isoforms
display different biological functions and pharmacological effects (Pan et al., 1998). Thus, it is important to
examine the expression pattern of Oprl1 splicing variants
in the hippocampus developmentally.
We measured mRNA levels of Oprl1 variants in the
hippocampus of control mice at P7, P21, and P100. P7
represents the first rapid stage of brain development postnatally in rodents (Gottlieb et al., 1977). We first measured total Oprl1 mRNA at the three time points
examined to determine if there is a sex difference. P7
mice expressed the highest mRNA levels of total Oprl1
while P21 and P100 mice expressed similar mRNA levels
of total Oprl1 in both sexes with higher expression levels
in males at P7 and P21 (Figure 5c). Among 12 variants
(V), V1–10 and 12 were detected (Figure 5d). In general,
the younger the mice, the lower levels of V1, 3, 5, and
8 were detected in the hippocampus. While the younger
the mice, the higher levels of V2, 4, 6–7, and 9–10 were
detected at the same time in the hippocampus. V12 was
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F I G U R E 5 Developmental expression pattern of Oprl1 total and its variants in the hippocampus. Data were presented as mean ± SD.
(a) A schematic of mouse Oprl1 gene. White boxes represent noncoding exons while black boxes represent coding exons. Gray boxes
represent nonsense mediated decay exons. (b) A schematic representation of Oprl1 splicing variants. Numbers on the left represent the
designations of the variants according to the information from NCBI and Ensembl. The horizontal line above exon(s) of each variant
represents the location of the primers for the variant. (c) Total Oprl1 mRNA expression in the hippocampus at three different time points.
(d) Heat map represents the developmental expression levels of V1-10 and V12 in the hippocampus at three different time points. The
numbers in the heat map represent the means of the variants at each time point. The gradient color bar represents different expression levels
with blue represents low expression levels while red represents high expression levels. N = 3 L/group. *p < .05 compared to P7, **p < 0.01
compared to P7, ^p < .05 compared to females

expressed at similar levels cross three different time
points. V10 was predominantly expressed while V3 was
the least expressed in the hippocampus. A sex difference
was noted at P7 for V3, 4, and 12 and at P100 for V1. We
then examined the effects of AME and AME-WD on the
expression of Oprl1 coding variants (V1–9 and 12) in the
hippocampus at P21 and P100.

3.4 | AME-WD increased hippocampal
Oprl1 V4 levels in males at P21 and P100
In P21 males, AME significantly increased hippocampal
V4 but decreased V1 levels when compared to the controls (Figure 6a). In P21 females, AME significantly
increased hippocampal V4 and V7 levels compared to the
controls (Figure 6b).

In P100 males, AMEM-WD also significantly increased
hippocampal V4 levels compared to either ConM-CD or
ConM-WD or AMEM-CD. Moreover, AMEM-WD significantly increased hippocampal V1–2 levels when compared
to either ConM-WD or AMEM-CD (Figure 6c). Yet, in P100
females, hippocampal Oprl1 variant levels were differentially affected in different experimental groups. In summary, AMEF-WD significantly decreased hippocampal V4,
V6, and V7 levels when compared to ConF-CD. AMEF-CD
also significantly increased hippocampal V2 and V9 levels
when compared to ConF-CD (Figure 6d).

4 | DISCUSSION
An AME and the consumption of a WD impair offspring
learning and memory functions later in life. Activation of
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F I G U R E 6 Hippocampal expression of Oprl1 coding variants in P21 and P100 offspring. Data were presented as mean ± SD.
(a) Hippocampal expression of Oprl1 variants in P21 females. (b) Hippocampal expression of Oprl1 variants in P21 males. *p < .05 when
compared to sex-matched controls. (c) Hippocampal expression of Oprl1 variants in P100 females. (d) Hippocampal expression of Oprl1
variants in P100 males. N = 6 L/group. *p < .05 when compared to sex-matched Con-CD, #p < .05 when compared to sex-matched Con-WD,
&
p < .05 when compared to sec-matched AME-CD. AME, adverse maternal environment; CD, control diet; WD, Western diet

N/OPQ signaling through its cognate receptor NOP also
impairs memory (Ke et al., 2020; Redrobe et al., 2000;
Sardari et al., 2015). We therefore hypothesized that
AME and postweaning WD alter variant expression of
Oprl1 and Oprl1 promoter histone code in an established
model of AME and postweaning WD characterized by
male offspring memory impairment. We found that AME
increased the expression of Oprl1 and variant V4 concurrently with the accumulation of activating histone mark
H3K9ac, H3K14ac, and H3K36me3 in the promoter
region in juvenile male mouse hippocampus. Importantly, these changes persist into adulthood in male
AME-WD mice. These findings suggest that early life
stress and diet endured by the mother affect Oprl1
expression via an epigenetic mechanism in the hippocampus. Moreover, a postweaning WD sustains an
altered epigenetic Oprl1 profile into adulthood, which in
turn may contribute to cognitive impairment later in life.
To our knowledge, this is the first evidence that an AME
and an AME-WD affect the expression of Oprl1 and its

splice variant concurrent with altered histone code in the
promoter in offspring hippocampus.
AME and postweaning WD impair cognitive function
in adult males in our model. In our previous study, we
found that male AME-WD mice took significantly more
time finding the platform compared to male control mice
(Con-CD) on Days 1 and 5 of Morris Water Maze testing,
a hippocampus-dependent functional test, indicating that
both nonspatial and spatial learning and memory are
impaired (Ke et al., 2020). Our findings revealing AME
and AME-WD induced an upregulation of Oprl1 expression in male offspring HP in this study suggest that upregulation of Oprl1 may play a role in impaired cognitive
function in this model. Our data are consistent with studies
showing that dexamethasone exposure in the neonatal
period increases Oprl1 mRNA levels in adult male rats with
subsequent decreased cognitive function (Chang, 2014; Neal
Jr et al., 2003). Additionally, increasing Oprl1 activity
through a pharmacological approach (Oprl1 agonists'
administration) impairs spatial learning and memory while
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this effect is attenuated via Oprl1 antagonists' administration in adult rats (Redrobe et al., 2000; Sardari et al., 2015).
Furthermore, transgenic studies reveal that deletion of
Oprl1 in mice improves performance in memory tests that
are highly dependent on hippocampal functioning
(Andero, 2015; Kuzmin et al., 2009; Taverna et al., 2005).
Taken together, these observations suggest that Oprl1 may
regulate hippocampal dependent memory functions.
Our observation that an AME-WD increases hippocampal Oprl1 expression in juvenile males provides further relevant context to previous findings. An AME
impairs neurogenesis in juvenile male HP by decreasing
cell proliferation (Ki67+ cells), neuronal differentiation
(NeuroD1+ cells), and the numbers of mature neurons
(NeuN+ cells) in the dentate gyrus region (Ke, Huang,
et al., 2021). Similarly, pharmacological blockade of
Oprl1 increases the number of immature neurons (DXC+
cells), thereby restoring chronic mild stress-induced neurogenesis impairment in adult male rat hippocampus
(Vitale et al., 2017). While we establish an association
between upregulated hippocampal Oprl1 expression and
impaired cognitive function, as well as decreased neurogenesis in our study, the underline mechanisms require
further investigations.
Although hippocampal Oprl1 mRNA levels are also
increased in juvenile AME females, the protein levels are
not affected in this study, suggesting that posttranscriptional regulations may be involved in the female
HP. Despite WD decreased Oprl1 abundance in CA1 and
CA3 region in both ConF-WD and AMEF-WD, overall
hippocampal Oprl1 expression is not affected at either
mRNA levels or protein levels in adult females in any
experimental groups, which is consistent with nonaffected learning and memory functions seen in this model.
These results imply that an AME affects Oprl1 expression
in a sex-specific manner. Future studies are warranted to
investigate underline mechanisms.
This study also demonstrates regional variation in terms
of the vulnerability of the developing hippocampus relative
to the insults used in this study. AME predominantly
affected hippocampal CA3 region through increased Oprl1
expression in juvenile males while AME-WD increased
Oprl1 abundance mainly in CA1 and CA3 regions in adult
males when compared to the controls. Hippocampal CA1
and CA3 are both required for contextual encoding of
extinction (Ji & Maren, 2008). The CA1 region is essential
for context-dependent retrieval whereas the CA3 region
contributes to acquiring and encoding spatial information
and plays a critical role in long-term spatial memory
(Cherubini & Miles, 2015; Gilbert & Brushfield, 2009;
Holahan & Routtenberg, 2011; Ji & Maren, 2008). Our findings may be a byproduct of the normal developmental pattern of hippocampal Oprl1 expression with early life
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expression being confined predominantly to the CA3 region
by spreading to CA1 region later in life thereby being
affected by the postweaning WD. Our findings of increased
Oprl1 expression in CA1 and DG regions in AMEM-WD
when compared to AMEM-CD that indicates a diet effect.
Furthermore, our data of increased Oprl1 expression in the
CA3 region in AMEM-WD when compared to ConM-WD
indicates an AME effect. Collectively, our data suggest that
an AME plus a second hit by a postweaning WD are necessary for the upregulation of Oprl1 expression in male adult
hippocampus seen in this model.
Regulation of Oprl1 expression involves histone modifications in the promoter (Caputi et al., 2014, 2016). Previous studies add relevance to our findings. For example,
decreased H3K9ac occupancy at Oprl1 promoter reduces
Oprl1 expression levels after acute and repeated
3,4-methylenedioxy-methamphetamine (MDMA) exposure (Caputi et al., 2016). Respective changes in the activating H3K4me3 and repressive mark H3K27me3
occupancy led to the anticipated changes in the Oprl1
promoter consistent after cocaine exposure (Caputi
et al., 2014). Similarly, we demonstrated that increased
occupancy of activating histone marks H3K9ac,
H3K14ac, and H3K36me3 at hippocampal Oprl1 promoter occurs concurrently with upregulated Oprl1
mRNA levels in male juvenile AME HP. Increased densities of these three active marks at hippocampal Oprl1
promoter persist into adulthood as do the changes in
Oprl1 hippocampal expression from AME-WD males.
Finally, H3K36me3 occupancy enriches the body of
active genes and appears to be associated with transcriptional elongation (Mikkelsen et al., 2007; Wang
et al., 2018). H3K36me3 also plays a role in transcriptional initiation (Wang et al., 2018; Zhang et al., 2014).
Indeed, increased H3K36me occupancy in the IGF1 promoter region occurs concurrently with upregulated IGF1
expression induced by CCI in juvenile rat HP (Schober
et al., 2012). Together, our data suggest that enriched
activating histone code at Oprl1 promoter contribute to
upregulation of Oprl1 expression in male HP at both time
points.
Our findings of increased repressive mark H3K27me3
densities in the Oprl1 promoter region in both AMEMCD and AMEM-WD groups indicate an AME effect and
the existing of bivalent histone modifications. Bivalent
histone modifications that are characterized by being
marked with opposing histone modifications correlate
with both a “repressive” and “active” gene expression
and are often seen in embryonic stem cells (Tomomi
Tsubouchi, 2013). The presence of “bivalent” histone
modifications at the promoters of lineage-specifying
genes has been implicated in establishing a chromatin
context in which multiple lineage options are primed in
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readiness for subsequent developmental cues (Tomomi
Tsubouchi, 2013). We have previously shown that bivalent histone modifications also exist in both promoter
and the body of IGF1 gene in the hippocampus of preterm lambs exposed to noninvasive ventilation at P21
(Ke, Xing, et al., 2021). Yet, the role of AME-induced
bivalent histone modifications seen in the adult mice in
this study is unknown.
Alternative splicing of Oprl1 gene generates multiple
variants (Curro et al., 2001; Pan et al., 1998). Five different splice variants with differential regional expressions
occur in the mouse brain (Pan et al., 1998). We found
11 Oprl1 mRNA variants with differential expression pattern in the hippocampus. The expression levels of V1,
3, 5, and 8 trend lower in younger mouse hippocampus
with V2, 4, 6–7, and 9–10 trending higher. Our findings
imply that different Oprl1 variants may play a role at different stages during hippocampal development. V1 exists
as a canonical transcript and encodes Oprl1 protein
KOR-3 (UniProtP35377). V3–4 and 6–8 encode KOR-3d,
KOR-3a, KOR-3b, KOR-3c, and KOR-3e isoforms, respectively (Pan et al., 1998). Different pharmacological
responses to agonists characterize these different variants
and isoforms (Pan et al., 1998). Our findings of sex differences in Oprl1 total mRNA and a few variants suggest
that endogenous sex steroids may play a role in these
changes.
Our findings of AME-WD leading to increased hippocampal Oprl1 V4 mRNA levels in adulthood suggest that
increased V4 levels may account for elevated total Oprl1
levels seen in this model. V4 contains an additional internal exon, which results in translation initiation from an
alternate start codon compared to V1. The encoded isoform KOR-3a is shorter with a distinct N-terminus compared to isoform KOR-3 (Acc# NM_001318922.1). This
truncated isoform may affect Oprl1 biological functions
that require further investigations. Furthermore, hippocampal V4 and V7 levels are increased in AME juvenile
females. However, hippocampal V4 and V7 levels are
decreased in AME-WD adult females that are in accord
with nonaffected cognitive function. While the Oprl1
genetic variants have been shown to be altered in neuropsychiatric disorders (Andero et al., 2013; Briant et al., 2010),
our data demonstrate that an AME and an AME-WD affect
Oprl1 expression in a variant-specific and sex-specific manner. We speculate that aberrant expression levels of V4 may
contribute to upregulated Oprl1 expression in affected HP
and subsequently lead to learning and memory impairment
seen in males in our model.
All molecular analyses performed in this study utilized
whole homogenized hippocampus, thus limiting our ability
to understand the contribution of hippocampal subfields but
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allowed for a comprehensive hippocampal investigation.
Future studies include FISH probes for RNA may delineate
region specificity. Another limitation is that this study
did not directly link Oprl1 expression after an AMEWD and neurogenesis that may be a mechanism for
hippocampal dysfunction. Future studies are warranted to investigate the mechanisms underline using
an Oprl1 agonist in vivo and siRNA knock down
in vitro.
In summary, we demonstrate that AME increases
Oprl1 total and V4 expression in association with altered
histone code at Oprl1 promoter in male juvenile hippocampus. Furthermore, an AME plus a second hit by a
postweaning WD shows the similar effects on gene
expression and histone code in male adult hippocampus.
These results advance the field by providing the first
report of altered Oprl1 mRNA variant expression and histone code in the promoter in the hippocampus of male
mice exposed to AME and second hit.
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